Taku Miyashita
Teikyo University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Taku Miyashita.
Journal of Gastroenterology | 1994
Taku Miyashita; Etsuo Hoshino; Tetsuo Imamura; Kouta Okinaga; Ieo Akaoka; Hideo Miyashita
Appendiceal cancer associated with pseudomyxoma peritonei is a low grade malignancy and its extraperitoneal metastasis is extremely rare. We report a case of gastric metastasis of this tumor in a 76-year-old man. Two metastatic gastric tumors, which appeared after a 1-year interval, were successfully resected endoscopically. The patient was well for more than 3 years after the onset of the disease. To our knowledge, gastric metastasis from appendiceal cancer with pseudomyxoma peritonei has not been previously reported.
Chemotherapy | 1994
Yasuo Ono; Otohiko Kunii; I. Ohyatsu; Y. Tokumura; Taku Miyashita; Masumi Aoki; Hajime Sugiyama; Hajime Nishiya; Hideo Miyashita; E. Goldstein
The immunomodulatory activity of cefodizime (CDZM), an aminothiazolylcephalosporin, was compared to that of HBW 538, a derivative of the CDZM side chain at position 3 (the mercaptothiazolyl group) in respect to the production of reactive oxygen species (ROS) by human whole blood and polymorphonuclear leukocytes (PMN) in vitro. Ten-fold diluted whole blood and PMN from healthy individuals were incubated with CDZM or HBW 538 alone at the concentrations of 1, 10, or 100 micrograms/ml, or CDZM or HBW 538 at 100 micrograms/ml in combination with tumor necrosis factor-alpha (TNF-alpha) at 100 U/ml or lipopolysaccharide (LPS) at 1 microgram/ml. The production of ROS was measured by a chemiluminescence (CL) assay in which luminol was added to a mixture and after which the PMN or whole blood were stimulated with nonopsonized zymosan or phorbol myristate acetate. The following results were obtained: (1) The CL responses of whole blood and PMN were slightly but not significantly enhanced by CDZM at 100 micrograms/ml, whereas both CL responses were significantly enhanced by exposure to HBW 538 at 10 and 100 micrograms/ml. (2) The enhanced PMN CL response which followed priming with TNF-alpha or LPS was not augmented by CDZM but was significantly augmented by HBW 538. These results indicate that the ability of the HBW 538 molecule to enhance the production of ROS by stimulated PMN and to act agonistically with TNF-alpha or LPS is abrogated when HBW 538 is part of the CDZM molecule.(ABSTRACT TRUNCATED AT 250 WORDS)
Digestive Diseases and Sciences | 1999
Taku Miyashita; Katsumi Murata; Etsuo Hoshino; Hajime Nishiya; Yasuo Ono; Ieo Akaoka
Although the use of intraperitoneal mucolytic agents is useful in the management of pseudomyxoma peritonei, effective removal of mucin is difficult even by repeated mucolysis in cases with massive ascites. To establish mucolytic therapy as a further effective procedure, biochemical analysis of mucin is required in greater detail. We reported here a case of pseudomyxoma peritonei caused by primary appendiceal cancer with biochemical analysis of mucin. The abdominal cavity in this case was filled with massive mucinous ascites. Although the mucolytic therapy was performed repeatedly, it was not effective in preventing mechanical ileus which was followed by surgical exclusion. Biochemical study of mucin showed that the mucin contained a small amount of hyaluronic acid, as characterized by electrophoretic study. These data led us to the hypothesis that the hyaluronic acid component plays a role in the pathogenesis of the replacement of mucin in the abdominal cavity.
Journal of Infection and Chemotherapy | 2002
Taku Miyashita; Yuko Shimamoto; Hajime Nishiya; Yoji Koshibu; Hajime Sugiyama; Yasuo Ono; Takayoshi Satoh; Hitomi Haraoka; Junichi Nakano; Ken Ohta; Tomohide Sato; Naoko Morinaga; Masatoshi Noda
Internal Medicine | 1994
Taku Miyashita; Tetsuo Imamura; Yasuro Ishikawa; Kouta Okinaga; Otohiko Kunii; Hideo Miyashita
Journal of Infection and Chemotherapy | 2000
Hajime Sugiyama; Eri Ogata; Yuko Shimamoto; Youji Koshibu; Kaoru Matsumoto; Keiko Murai; Taku Miyashita; Yasuo Ono; Hajime Nishiya; Otohiko Kunii; Tomohide Sato
The Journal of the Japanese Association for Infectious Diseases | 1994
Yasuo Ono; Yasuaki Tokumura; Taku Miyashita; Kunio Kobayashi
The Journal of the Japanese Association for Infectious Diseases | 1998
Taku Miyashita; Junko Kato; Yasuo Ono; Keiko Kawamata; Tadashi Ito; Hajime Sugiyama; Kaoru Matsumoto; Yuko Shmamoto; Hajime Nishiya; Tomohide Sato
The Journal of the Japanese Association for Infectious Diseases | 1997
Hajime Sugiyama; Keiko Kawamata; Junko Katoh; Taku Miyashita; Tadashi Itoh; Isao Ohyatsu; Masumi Aoki; Yasuo Ono; Hajime Nishiya; Tomohide Satoh
The Journal of the Japanese Association for Infectious Diseases | 1995
Yasuo Ono; Megumi M; Hajime Sugiyama; Yasuaki Tokumura; Isao Ohyatsu; Taku Miyashita; Junko Kato; Hajime Nishiya; Hideo Miyashita